Sign in

You're signed outSign in or to get full access.

Peter M. Graham

About Peter M. Graham

Independent director of Montrose Environmental Group (MEG) since June 2017; age 70. He is a private investor and partner at One Better Ventures LLC, with prior roles including Chairman of Seventh Generation (sold to Unilever in 2016), board and audit chair of Thrive Acquisition Corporation (SPAC), and senior leadership at Ladenburg Thalmann; he brings significant finance and capital markets expertise and extensive public and private board experience . The Board has affirmatively determined he is independent under NYSE rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Seventh Generation, Inc. (private)Chairman of the Board~17 years; through Oct 2016 sale to UnileverLong-tenured governance leadership at a consumer products company
Thrive Acquisition Corporation (public SPAC)Director; Audit Committee ChairSep 2021 – Jan 2023Led audit oversight at a public company
ExamWorks Group, Inc. (public)DirectorUntil May 2016Served on audit, compensation, and nominating & corporate governance committees
Ladenburg Thalmann Group Inc. (finance)Principal, President, Vice ChairmanUntil 2004Capital markets and leadership experience

External Roles

OrganizationRoleTenureNotes
One Better Ventures LLCPartnerSince Jun 2017Private advisory and investment firm

Board Governance

  • Independence status: Independent director; Board and all committees (Audit, Compensation, Nominating & Corporate Governance) comprised solely of independent directors during 2024 .
  • Board leadership: Non-executive Chairman (R. E. Perlman); therefore no Lead Independent Director; independent directors meet in executive session with Chairman presiding .
  • Attendance: Board held 10 meetings in 2024; all directors attended at least 75% of Board and committee meetings and attended the 2024 annual meeting .
  • Committee assignments (2024): Compensation Committee Chair; Audit Committee member .
CommitteeRole2024 MeetingsNotes
CompensationChair2Committee entirely independent; oversees NEO pay, equity plans, and director compensation
AuditMember8Committee entirely independent; financial reporting, internal controls, auditor oversight. Audit “financial expert” designation applies to Presby and Colman, not Graham
Nominating & Corporate Governance4Not a member

Governance engagement: As Compensation Committee Chair, Graham participated directly in expanded investor outreach following weak 2023 votes and in 2024–2025 stewardship discussions .

Fixed Compensation (Director)

Director pay was unchanged in 2024 versus 2023 and 2022. Cash includes the standard annual retainer plus the Compensation Chair fee; equity is time-vesting RS .

Component (FY2024)AmountDetails
Annual cash retainer$90,000Paid quarterly in arrears
Committee chair fee (Compensation)$30,000Chair premium
Total cash (reported)$120,000Matches cash line in director comp table
Annual equity grant$109,9813,423 RS (closing price $32.13 on 12/29/2023); vests on 1-year anniversary
Total (cash + equity)$229,981As disclosed for Peter M. Graham

Performance Compensation (Director)

  • No performance-based components for director compensation; annual equity awards are time-based restricted stock that vest after one year .

Other Directorships & Interlocks

  • Current public company boards: None disclosed as current; prior public board roles include Thrive Acquisition Corporation and ExamWorks Group, Inc. .
  • Interlocks/potential network ties: Several current MEG directors/executives are ExamWorks founders/executives (e.g., Richard E. Perlman, James K. Price, J. Miguel Fernandez de Castro), where Graham previously served as a director and committee member—an interlock that can raise independence perception risk despite formal independence .

Expertise & Qualifications

  • Core credentials: Extensive board leadership (including committee chair roles), investment banking and capital markets experience, and long-tenured governance at mission-driven consumer and services businesses .
  • Financial literacy: Serves on Audit Committee; committee members are financially literate under NYSE rules (audit “financial expert” designation is held by Presby and Colman) .

Equity Ownership

ItemValueNotes
Beneficial ownership (common shares)222,259Less than 1% of outstanding shares
Unvested RS outstanding at 12/31/20243,423Director RS vested on Jan 1, 2025
OptionsNone disclosed for GrahamOptions shown only for certain directors; none for Graham in 2024 table
Stock ownership guidelines5x annual cash retainer ($450,000) for non-management directors; 5-year phase-in from IPO/appointment; all non-management directors exceeded or on track as of Jan 31, 2025

Policy alignment:

  • Anti-hedging: Prohibits directors, officers, employees from short-term trading, short sales, derivatives, and hedging in Company stock .
  • Clawback: Robust Dodd-Frank-compliant clawback for incentive-based executive pay (3-year lookback) demonstrates compensation governance rigor (primarily executive-focused) .

Compensation Committee Oversight (as Chair)

  • Shareholder feedback response: Following low support in 2023 and only 51.9% Say-on-Pay support in 2024, the committee (chaired by Graham) led changes: cancellation of 2021 SARs without replacement; commitment to end acquisition-based bonuses for most NEOs from 2025; plan to adopt annual LTI grants from 2027 with at least 50% performance-based .
  • Consultant: Exequity LLP engaged as independent advisor; Compensation Committee assessed and found no conflicts of interest .
  • Peer benchmarking: Committee refreshed peer group in 2023 to inform 2024 pay decisions; uses peer data and broader surveys without targeting a specific percentile .

Related Party & Conflict Review

  • Investor Rights Agreement: Graham is among directors party to the Third Amended and Restated Investors’ Rights Agreement with Oaktree and others (includes certain registration and rights-of-first-offer provisions), which is monitored under the Related Person Transaction Policy .
  • Committee interlocks: Proxy states no compensation committee interlocks with executive officers of other companies; any related transactions are reviewed per policy .

Signals for Investors (Board Effectiveness, Risks, Red Flags)

  • Positive governance signals:
    • Independent status; leadership as Compensation Chair; active investor outreach; structural improvements (e.g., declassification proposal; director resignation policy) .
    • Director ownership guidelines and anti-hedging policy support alignment .
  • Watch items / red flags:
    • Say-on-Pay support only 51.9% in 2024 (improved from 2023 but still weak), placing scrutiny on Compensation Committee oversight; subsequent actions (SAR cancellation, program changes) are responsive but execution will be monitored .
    • Historical ties among multiple directors via ExamWorks may create perceived interlocks; continued emphasis on refreshment and diversity of experience is prudent .
    • Compensation Committee met twice in 2024 vs. Audit Committee’s eight meetings; given the magnitude of executive pay redesigns underway, investors may watch committee cadence and disclosure depth in 2025–2027 .

Quantitative Reference Tables

Director Compensation (FY2024)

MetricAmount
Fees earned or paid in cash ($)$120,000
Stock awards ($)$109,981
Total ($)$229,981
Shares in 2023 year-end grant3,423 RS (at $32.13)
VestingOne-year from grant date (vested Jan 1, 2025 for 2023 grant)

Board & Committee Workload (2024)

BodyMeetings
Board of Directors10
Audit Committee8
Compensation Committee2
Nominating & Corporate Governance Committee4

Ownership & Alignment

ItemValue
Beneficial ownership (shares)222,259; <1% of outstanding
Unvested RS at 12/31/20243,423 (vested 1/1/2025)
Director stock ownership guideline5x cash retainer ($450,000); exceeded/on track as of 1/31/2025

Say-on-Pay & Engagement

ItemValue/Status
2024 Say-on-Pay support51.9%
Committee/Board responsesCanceled 2021 SARs; ending acquisition-based bonus (most NEOs) from 2025; shift to annual, 50%+ performance-based LTI from 2027

Governance Assessment

  • Graham is a seasoned independent director with deep capital markets and board governance expertise, currently chairing MEG’s Compensation Committee and serving on the Audit Committee . He has been central to investor engagement and pay program resets following weak Say-on-Pay results, including canceling legacy SARs and committing to more performance-based, annually granted LTI beginning in 2027 . While independence is affirmed, legacy ExamWorks ties among several directors present interlock optics to monitor, alongside the execution of compensation reforms and continued improvement in shareholder support trends .